- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- 2025-07-05, 19:53:24
- Local Time:
- 2025-07-19, 04:52:57
- Last Active:
- 2025-07-05, 22:33:37
Signature:
Infliximab-IRDye800CW and rituximab-IRDye800CW are used as controls.UCCs show prominent uPAR expression at the tumour-stroma interface and EpCAM